NCT06967285 Prone Positioning in ARDS: Predicting Neurological Complications Via Cerebral Hemodynamics
| NCT ID | NCT06967285 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sichuan Provincial People's Hospital |
| Condition | ARDS (Moderate or Severe) |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-03-19 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-03-19 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prone Positioning in ARDS: Predicting Neurological Complications via Cerebral Hemodynamics
Eligibility Criteria
Inclusion Criteria: * Age≥18 years * Meet the diagnostic criteria for ARDS(Acute Respiratory Distress Syndrome),with PaO₂/FiO₂\<150 mmHg,and requiring prone ventilation * Expected duration of mechanical ventilation\>48 hours * Written informed consent obtained Exclusion Criteria: * Presence of contraindications to prone positioning(e.g.,head and neck injuries,spinal instability,severe intracranial hypertension) * Severe neurological diseases(e.g.,cerebral hemorrhage,cerebral infarction,intracranial space-occupying lesions)that may affect the monitoring of cerebral hemodynamics * Life-threatening ARDS * Patients who are unable to undergo neurological assessment * Poor image quality or absence of images
Contact & Investigator
lingai Pan, PhD
STUDY CHAIR
Sichuan Provincial People's Hospital
Frequently Asked Questions
Who can join the NCT06967285 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ARDS (Moderate or Severe). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06967285 currently recruiting?
Yes, NCT06967285 is actively recruiting participants. Contact the research team at panlingai2004@163.com for enrollment information.
Where is the NCT06967285 trial being conducted?
This trial is being conducted at Chengdu, China.
Who is sponsoring the NCT06967285 clinical trial?
NCT06967285 is sponsored by Sichuan Provincial People's Hospital. The principal investigator is lingai Pan, PhD at Sichuan Provincial People's Hospital. The trial plans to enroll 50 participants.